Skip to main content
Login
Contact
Subscribe
Search form
Search
The Evening Leader?
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Classified Display Ads
Service Directory
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Viveve Medical
(NQ:
VIVE
)
1.040
USD
-0.050 (-4.59%)
Official Closing Price
/ Updated:
5:07 PM EST, Feb 20, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
212,141
Open
1.100
Bid (Size)
1.000 (200)
Ask (Size)
1.710 (10)
Prev. Close
1.090
Today's Range
1.030 - 1.120
52wk Range
0.9300 - 4.590
Shares Outstanding
31,269,388
Dividend Yield
N/A
Performance
YTD
-6.31%
-6.31%
1 Month
-8.77%
-8.77%
3 Month
-53.57%
-53.57%
6 Month
-67.40%
-67.40%
1 Year
-76.15%
-76.15%
Top News
More News
Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 Revenue Guidance and Provides Corporate Update
January 16, 2019
Viveve Medical Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today reported preliminary financial results for the full year ended December 31, 2018 and provided...
Read More
from
GlobeNewswire News Releases
Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence
January 03, 2019
Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, announced today that it has completed enrollment in its LIBERATE-International trial, a...
Read More
from
GlobeNewswire News Releases
More News
Read More
Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment
December 20, 2018
from
GlobeNewswire News Releases
Viveve Announces Closing of Public Offering of Shares of Common Stock
December 11, 2018
from
GlobeNewswire News Releases
Viveve Announces Pricing of Public Offering of Shares of Common Stock
December 06, 2018
from
GlobeNewswire News Releases
Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study
December 06, 2018
from
GlobeNewswire News Releases
Viveve Announces Proposed Public Offering of Shares of Common Stock
December 06, 2018
from
GlobeNewswire News Releases
Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders
November 29, 2018
from
GlobeNewswire News Releases
New Research Coverage Highlights Chuy's, Viveve Medical, ClearSign Combustion, WhiteHorse Finance, Crinetics Pharmaceuticals, and Boston Omaha — Consolidated Revenues, Company Growth, and Expectations
November 21, 2018
from
GlobeNewswire News Releases
Viveve Named One of North America’s 500 Fastest Growing Companies by Deloitte
November 15, 2018
from
GlobeNewswire News Releases
7 Stocks To Watch For December 7, 2018
December 07, 2018
category
UNFI
,
AOBC
,
ZUMZ
, and 13 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
X
Username
*
Password
*
Request new password